Background: Aluminium-containing phosphate binders have long been used for treatment of hyperphosphatemia in dialysis patients. Their safety became controversial in the early 1980's after reports ...

The treatment of hyperphosphatemia was intensified by the additional mealtime administration of phosphate binders, such as aluminium hydroxide and calcium carbonate. Phosphate accumulation was ...

A notable development is the decision to include phosphate binders in the payment bundle, a move that was anticipated but is not expected to serve as a significant positive catalyst for providers like ...

After hours: September 30 at 7:58 PM EDT Loading Chart for CAT ...